James M. Frincke is Chief Scientific Officer at HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH). They have made 2 open-market trades across 1 company since 2007, most recently 2011-10-28.
CIK 0001239656
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $11K since 2011, never a sale. Too few scored purchases to measure a record yet.